HFA Cardio Talk

About HFA Cardio Talk

The HFA Cardio Talk provides the opportunity to anyone interested in Heart Failure to receive updates in the field with very specific and diverse topics, go on a deeper subject of an HFA course and to listen to a discussion of key opinion leaders with junior HF specialists. Each month, a new episode lasting approximately 15 minutes and taking the form of a conversation between a member of the HFA Young community and an internationally renowned expert is released. You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk, ESC TV Today and much more. Check them out!

Publisher

European Society of Cardiology

Category

education · health & fitness

Language

en

Explicit

No

First episode

27 Jan 2022

Latest episode

16 Sept 2026

Latest episodes

58 episodes in the feed.

1. 

   16 Sept 2026

   Late-breaking clinical science from ESC Congress 2026

   With Gregorio Tersalvi, Mayo Clinic, Rochester, Minnesota - USA, Lars Kober and Jawad Haider Butt, Rigshospitalet - Copenhagen University Hospital, Copenhagen - Denmark, Jolie Bruno, Inselspital, Bern University Hospital, University of Bern, Bern - Switzerland, Jorg Hausleiter, LMU University Hospital, LMU Munich, Munich - Germany, Benedikt Norbert Beer, University Medical Center Hamburg-Eppendorf, Hamburg - Germany, Marianna Adamo, University and Civil Hospital of Brescia, Brescia - Italy and Novi Yanti Sari, Siloam Hospitals Group, Jakarta - Indonesia. In this episode, we discuss the late-breaking clinical science presented at ESC Congress 2026 in Munich, Germany. First, Jolie Bruno interviews Lars Kober and Jawad Haider Butt on hydralazine plus isosorbide dinitrate in HFrEF, covering the results of the H-HeFT trial and of the accompanying H-ISDN meta-analysis. H-HeFT compared H-ISDN with placebo in patients with symptomatic heart failure and an ejection fraction of 40% or less, while the meta-analysis pooled three placebo-controlled trials to assess the effect of H-ISDN on mortality and heart failure events. Next, Benedikt N. Beer interviews Jorg Hausleiter, who highlights the key findings of TRIC-I-HF, a randomised, open-label trial of transcatheter tricuspid valve repair on top of medical therapy versus medical therapy alone in patients with severe tricuspid regurgitation and heart failure. Finally, Novi Yanti Sari interviews Marianna Adamo, who co-chaired the 2026 ESC Guidelines for the management of heart failure and outlines the main novelties of the document. This 2026 HFA Cardio Talk podcast series is supported by Bayer in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsor. Presenter: Gregorio Tersalvi, Mayo Clinic, Rochester, Minnesota - USA Segment 1: Title: H-HeFT: Hydralazine-Isosorbide Dinitrate in HFrEF + H-ISDN Meta-Analysis Results paper: not yet published Design paper: Wiggers H, Køber L, Gislason G, et al. The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT). Am Heart J. 2021;231:137-146. doi:10.1016/j.ahj.2020.09.020 Segment 2: Title: TRIC-I-HF (TRICuspid Intervention in Heart Failure) Results paper: Hausleiter J, Stocker TJ, Geisler T, et al. Tricuspid-Valve Intervention in Heart Failure. N Engl J Med. Published online August 30, 2026. doi:10.1056/NEJMoa2606934 Design paper: Stocker TJ, Geisler T, Rottbauer W, et al. Rationale and design of the TRIC-I-HF-DZHK24 (TRICuspid Intervention in Heart Failure) trial. Eur J Heart Fail. 2025;27(10):1895-1904. doi:10.1002/ejhf.3795 Segment 3: Title: Highlights from the 2026 ESC Guidelines for the management of heart failure Guideline paper: Køber L, Adamo M, Ruwald AC, et al. 2026 ESC Guidelines for the management of heart failure. Eur Heart J. Published online August 28, 2026. doi:10.1093/eurheartj/ehag100

2. 

   10 Aug 2026

   Progress in heart transplantation: DCD and beyond

   With Daniella Motta Da Costa Dan, Rede Meridional Hospital, Vitoria - Brazil and Linda Van Laake, University Medical Center Utrecht, Utrecht - The Netherlands. This episode discusses recent progress across the entire heart transplantation journey, from candidate selection to long-term follow-up. The conversation explores how clinicians should assess increasingly complex transplant candidates, including older or frail patients and those with several comorbidities. It also examines new strategies to expand the donor pool, with a special focus on donation after circulatory death, extended-criteria donors, hepatitis C-positive donors, machine perfusion and improved donor–recipient matching. Finally, the episode discusses advances in post-transplant care, including personalized immunosuppression, biomarkers, donor-derived cell-free DNA, gene-expression profiling and non-invasive graft surveillance. This 2026 HFA Cardio Talk podcast series is supported by Bayer in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsor.

3. 

   1 Jul 2026

   Cardiogenic shock - when to consider MCS

   With Cornelia Margineanu, University of Medicine and Pharmacy Carol Davila, Bucharest - Romania and Holger Thiele, Heart Center Leipzig at University of Leipzig, Leipzig - Germany. In this episode, Cornelia Margineanu interviews Holger Thiele on the practical approach to temporary mechanical circulatory support in heart failure. Specific examples and clinical scenarios in which temporary mechanical circulatory support (MCS) should be considered, as well as when patients should be referred to tertiary centres, are discussed. The differences between various MCS devices, including their advantages and limitations, are also explored, along with the key elements of patient monitoring. This 2026 HFA Cardio Talk podcast series is supported by Bayer in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsor.

Who has been a guest on HFA Cardio Talk

Names identified in recent episode analyses. Showing up to five guests.

• Kevin Damman
• Joao Pedro Ferreira
• Marat Fudim
• Jose Luis Morales Rull

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

3.3 / 5

3 ratings

Spotify

5.0 / 5

4 ratings

Podcast Authority Score: 39 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

49

Social presence

0

YouTube

0

Engagement

71

Contact HFA Cardio Talk

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  This Week in Cardiology

• 

  Eagle's Eye View: Your Weekly CV Update From ACC.org

• 

  Cardionerds: A Cardiology Podcast

• 

  ESC Cardio Talk

• 

  ESC TV Today – Your Cardiovascular News

• 

  Harrison's PodClass: Internal Medicine Cases and Board Prep